Market Forecast By Product Type (Reagents, Instruments, Software And Services), By Technique (Immunodiagnostics, Blood Testing, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, Other Ivd Techniques), By Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, Others Indications), By End Users (Standalone Laboratories, Hospitals, Academic And Medical Schools, Point Of Care Testing, Others End-User) And Competitive Landscape
| Product Code: ETC7545358 | Publication Date: Sep 2024 | Updated Date: Dec 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
According to 6Wresearch internal database and industry insights, the India IVD Market is projected to grow at a compound annual growth rate (CAGR) of 8.6% during the forecast period 2026–2032.
Below mentioned are the evaluation of year-wise growth rate along with key drivers:
| Year | Est. Annual Growth (%) | Growth Drivers |
| 2021 | 6.2 | Increased use of advanced diagnostic tools, growth in healthcare infrastructure. |
| 2022 | 6.5 | High demand for diagnostic testing due to awareness in healthcare and major health concerns. |
| 2023 | 7 | Government programs to development diagnostic infrastructure and increasing healthcare investments. |
| 2024 | 7.4 | Growing knowledge and affordability of diagnostic services across Tier 2 and Tier 3 cities. |
| 2025 | 7.8 | Rapid use of molecular diagnostics and genetic testing, along with major investment in diagnostic technologies |
The India IVD Market report thoroughly covers the market by product type, technique, application, and end-user. It provides an unbiased and detailed analysis of ongoing market trends, opportunities, challenges, and market drivers, helping stakeholders align their strategies with current and future market dynamics.
| Report Name | India IVD Market |
| Forecast period | 2026-2032 |
| CAGR | 8.6% |
| Growing Sector | Immunodiagnostics, Molecular Diagnostics |
India IVD market is expected to grow rapidly due to increasing health concerns, rising danger of chronic diseases, and a rapidly developing healthcare infrastructure. The reducing prices of diagnostic services in rural and semi-urban areas, as well as the growing healthcare sector, makes India an attractive market for both domestic and international IVD players. Advanced technologies in diagnostic such as molecular diagnostics, immunodiagnostics, and point-of-care (POC) testing are also changing the market demand. Government programs that aimed at improving healthcare services, increasing awareness about healthcare, and high demand of diagnostic testing are some of the major factors driving India IVD Market Growth.
Below mentioned are some prominent drivers and their influence on the India IVD Market dynamics:
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| Government Initiatives | All Segments | Government programs like PMJAY and NHM are developing healthcare infrastructure and increasing diagnostic access, especially in rural areas. |
| Healthcare Awareness | All Segments | Increased awareness of lifestyle diseases like diabetes, cancer, and cardiovascular diseases is increasing demand for diagnostic testing. |
| Technological Advancements | All Segments | New technologies in molecular diagnostics and POC testing are making diagnostics faster, more accurate, and affordable. |
| Rising Healthcare Expenditure | All Segments | Developing private and public healthcare spending is pushing diagnostic facilities, especially in urban areas, improving access to new diagnostic technologies. |
| AI and Data Analytics | All Segments | AI and big data solutions are making diagnostic processes better, optimizing operations, predicting trends, and better decision-making capabilities in the healthcare sector. |
India IVD Market is projected to grow at a compound annual growth rate (CAGR) of 8.6% from 2026 to 2032. Key factors that are driving this growth are increasing demand for diagnostic testing, new technologies in molecular diagnostics and point-of-care testing, and new and better government policies to improve infrastructure of healthcare. The opening of new diagnostic centres, especially in rural areas, and the change towards personalized medicine are also contributing to the market’s robust growth. The increased spreading of chronic diseases in young generation, lifestyle-related conditions, and infections, combined with the growing use of AI and digital health solutions, will drive major demand in the Indian IVD Market Industry.
Below mentioned are some major restraints and their influence on the India IVD Market dynamics:
| Restraints | Primary Segment Affected | Why It Matters (Evidence) |
| Regulatory Challenges | All Segments | Difficult rules and the certification process for development of new products can delay entry in the market, particularly for international players. |
| High Costs for Small Players | Small and Medium Enterprises | High prices of manufacturing and expensive technologies create many difficulties for smaller players which reduce the price of diagnostic solutions, especially in rural areas. |
| Limited Skilled Workforce | All Segments | Shortage of trained medical professionals and diagnostic technologists, especially in rural areas, reduce the development of new diagnostic techniques. |
| Data Privacy Concerns | All Segments | Concerns over privacy of personal data and theft of data are discouraging healthcare providers from buying diagnostic technologies. |
| Infrastructure Gaps | Rural Areas, Small Enterprises | Underdeveloped infrastructure of healthcare, particularly in rural areas, reduce the price of new and advanced diagnostic technologies. |
Several notable trends are shaping the India IVD Market dynamics:
Some notable investment opportunities in the India IVD Industry include:
Below is the list of prominent companies leading the India IVD Market:
| Company Name | Abbott Laboratories |
| Headquarters |
Chicago, USA (Strong presence in India) |
| Established | 1888 |
| Website | Click Here |
Abbott is a global leader in diagnostics, offering a broad portfolio of IVD products ranging from molecular diagnostics to point-of-care testing.
| Company Name | Siemens Healthineers |
| Headquarters |
Erlangen, Germany (Strong presence in India) |
| Established | 1847 |
| Website | Click Here |
Siemens Healthineers is a global leader in diagnostic imaging and laboratory diagnostics, providing a comprehensive range of molecular diagnostics, immunodiagnostics, and imaging technologies. In India, Siemens is heavily involved in the development of advanced diagnostic equipment and solutions that help healthcare providers improve clinical decision-making and patient outcomes.
| Company Name | Roche Diagnostics |
| Headquarters |
Basel, Switzerland (Strong presence in India) |
| Established | 1896 |
| Website | Click Here |
Roche Diagnostics is a world leader in in-vitro diagnostics, offering cutting-edge technologies and products in areas like molecular diagnostics, immunochemistry, and laboratory automation.
| Company Name | BD (Becton, Dickinson and Company) |
| Headquarters |
Franklin Lakes, New Jersey, USA (Strong presence in India) |
| Established | 1897 |
| Website | Click Here |
BD is a leading global medical technology company, specializing in diagnostic systems, instruments, and reagents.
| Company Name | Thermo Fisher Scientific |
| Headquarters |
Waltham, Massachusetts, USA (Strong presence in India) |
| Established | 1956 |
| Website | Click Here |
Thermo Fisher Scientific is a leading provider of laboratory instruments, molecular diagnostics, and clinical testing solutions. In
According the Indian government data, they have introduced many important programs to promote the growth of the IVD market. Programs like National Health Mission (NHM) focuses on improving healthcare delivery, particularly in rural areas, by increasing sale of essential diagnostic services. Ayushman Bharat, one of the largest healthcare schemes, provides funding for hospitals and diagnostic centres to upgrade their infrastructure and equipment, including IVD tools, thereby developing diagnostic capabilities across the country. These programs collectively contribute to the development and expansion of the IVD market in India, improving sales of healthcare and diagnostic nationwide.
India IVD Market is expected to have a steady growth due to increasing demand for diagnostic testing, especially for chronic and infectious diseases. Key drivers such as government programs, high awareness about healthcare, and new technological advancements in molecular diagnostics and immunodiagnostics will play an important role in shaping this market dynamics. Programs like National Health Mission (NHM) focuses on improving healthcare delivery, particularly in rural areas, by increasing sale of essential diagnostic services. The reducing prices of diagnostic services in rural and semi-urban areas, as well as the growing healthcare sector, makes India an attractive market for both domestic and international IVD players.
The report offers a comprehensive study of the following market segments and their leading categories:
According to Lakshita, Senior Research Analyst, 6Wresearch, Reagents are expected to dominate the market due to their critical role in diagnostic testing across various platforms. Reagents are widely used in molecular diagnostics, clinical chemistry, immunodiagnostics, and blood testing. Their extensive use in diagnostic kits, as well as in laboratory settings, contributes significantly to the market share. The demand for high-quality reagents is increasing as more advanced diagnostic solutions are developed.
Molecular diagnostics is expected to lead the market due to the increasing demand for precise, early, and personalized diagnostic testing. Molecular techniques such as PCR (Polymerase Chain Reaction) and genetic testing are gaining popularity, especially for detecting infectious diseases and cancer. As the need for advanced diagnostics grows, molecular diagnostic tools are becoming more integral in the clinical environment, driving the market forward.
Infectious diseases are expected to dominate the India IVD Market due to the growing incidence of diseases like tuberculosis, malaria, and COVID-19. The ongoing need for effective diagnostics for rapidly spreading infectious diseases drives high demand for IVD products. Additionally, applications in cancer and cardiac diseases are expected to see strong growth as the prevalence of lifestyle-related conditions rises.
Standalone laboratories are expected to dominate the India IVD Market Share due to their high volume of diagnostic testing, especially in urban areas. These laboratories play a crucial role in delivering diagnostic results quickly and efficiently. Hospitals are also major end users of IVD products, particularly in the diagnostic testing of inpatients.
The report offers a comprehensive study of the following India IVD Market segments:
| 1 Executive Summary |
| 2 Introduction |
| 2.1 Key Highlights of the Report |
| 2.2 Report Description |
| 2.3 Market Scope & Segmentation |
| 2.4 Research Methodology |
| 2.5 Assumptions |
| 3 India IVD Market Overview |
| 3.1 India Country Macro Economic Indicators |
| 3.2 India IVD Market Revenues & Volume, 2022 & 2032F |
| 3.3 India IVD Market - Industry Life Cycle |
| 3.4 India IVD Market - Porter's Five Forces |
| 3.5 India IVD Market Revenues & Volume Share, By Product Type, 2022 & 2032F |
| 3.6 India IVD Market Revenues & Volume Share, By Technique, 2022 & 2032F |
| 3.7 India IVD Market Revenues & Volume Share, By Application, 2022 & 2032F |
| 3.8 India IVD Market Revenues & Volume Share, By End Users, 2022 & 2032F |
| 4 India IVD Market Dynamics |
| 4.1 Impact Analysis |
| 4.2 Market Drivers |
| 4.2.1 Increasing prevalence of chronic diseases in India |
| 4.2.2 Growing geriatric population in the country |
| 4.2.3 Rising healthcare expenditure and increasing awareness about early disease detection |
| 4.2.4 Technological advancements in the IVD sector |
| 4.2.5 Government initiatives to improve healthcare infrastructure and access to diagnostics |
| 4.3 Market Restraints |
| 4.3.1 Lack of skilled healthcare professionals for conducting IVD tests |
| 4.3.2 Stringent regulatory requirements for product approval and market entry |
| 4.3.3 Price sensitivity among consumers hindering adoption of advanced IVD technologies |
| 4.3.4 Limited access to quality healthcare services in rural areas of India |
| 4.3.5 Competition from alternative diagnostic technologies |
| 5 India IVD Market Trends |
| 6 India IVD Market, By Types |
| 6.1 India IVD Market, By Product Type |
| 6.1.1 Overview and Analysis |
| 6.1.2 India IVD Market Revenues & Volume, By Product Type, 2022- 2032F |
| 6.1.3 India IVD Market Revenues & Volume, By Reagents, 2022- 2032F |
| 6.1.4 India IVD Market Revenues & Volume, By Instruments, 2022- 2032F |
| 6.1.5 India IVD Market Revenues & Volume, By Software And Services, 2022- 2032F |
| 6.2 India IVD Market, By Technique |
| 6.2.1 Overview and Analysis |
| 6.2.2 India IVD Market Revenues & Volume, By Immunodiagnostics, 2022- 2032F |
| 6.2.3 India IVD Market Revenues & Volume, By Blood Testing, 2022- 2032F |
| 6.2.4 India IVD Market Revenues & Volume, By Molecular Diagnostics, 2022- 2032F |
| 6.2.5 India IVD Market Revenues & Volume, By Tissue Diagnostics, 2022- 2032F |
| 6.2.6 India IVD Market Revenues & Volume, By Clinical Chemistry, 2022- 2032F |
| 6.2.7 India IVD Market Revenues & Volume, By Other Ivd Techniques, 2022- 2032F |
| 6.3 India IVD Market, By Application |
| 6.3.1 Overview and Analysis |
| 6.3.2 India IVD Market Revenues & Volume, By Infectious Diseases, 2022- 2032F |
| 6.3.3 India IVD Market Revenues & Volume, By Cancer, 2022- 2032F |
| 6.3.4 India IVD Market Revenues & Volume, By Cardiac Diseases, 2022- 2032F |
| 6.3.5 India IVD Market Revenues & Volume, By Immune System Disorders, 2022- 2032F |
| 6.3.6 India IVD Market Revenues & Volume, By Nephrological Diseases, 2022- 2032F |
| 6.3.7 India IVD Market Revenues & Volume, By Gastrointestinal Diseases, 2022- 2032F |
| 6.4 India IVD Market, By End Users |
| 6.4.1 Overview and Analysis |
| 6.4.2 India IVD Market Revenues & Volume, By Standalone Laboratories, 2022- 2032F |
| 6.4.3 India IVD Market Revenues & Volume, By Hospitals, 2022- 2032F |
| 6.4.4 India IVD Market Revenues & Volume, By Academic And Medical Schools, 2022- 2032F |
| 6.4.5 India IVD Market Revenues & Volume, By Point Of Care Testing, 2022- 2032F |
| 6.4.6 India IVD Market Revenues & Volume, By Others End-User, 2022- 2032F |
| 7 India IVD Market Import-Export Trade Statistics |
| 7.1 India IVD Market Export to Major Countries |
| 7.2 India IVD Market Imports from Major Countries |
| 8 India IVD Market Key Performance Indicators |
| 8.1 Adoption rate of IVD technologies in healthcare facilities |
| 8.2 Number of IVD tests conducted per capita |
| 8.3 Investment in research and development for new IVD products |
| 8.4 Percentage of healthcare budget allocated to diagnostic services |
| 8.5 Rate of integration of IVD technologies with electronic health records |
| 9 India IVD Market - Opportunity Assessment |
| 9.1 India IVD Market Opportunity Assessment, By Product Type, 2022 & 2032F |
| 9.2 India IVD Market Opportunity Assessment, By Technique, 2022 & 2032F |
| 9.3 India IVD Market Opportunity Assessment, By Application, 2022 & 2032F |
| 9.4 India IVD Market Opportunity Assessment, By End Users, 2022 & 2032F |
| 10 India IVD Market - Competitive Landscape |
| 10.1 India IVD Market Revenue Share, By Companies, 2022- 2032 |
| 10.2 India IVD Market Competitive Benchmarking, By Operating and Technical Parameters |
| 11 Company Profiles |
| 12 Recommendations |
| 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here